Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Eur J Clin Invest ; 37(12): 933-8, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17971175

ABSTRACT

BACKGROUND: Hyperhomocysteinaemia is a metabolic disorder associated with the development of premature atherosclerosis. Among the determinants which predispose to premature thromboembolic and atherothrombotic events, serum activity of paraoxonase 1, mainly synthesized in the liver, has been shown to be a predictor of cardiovascular disease and to be negatively correlated with serum homocysteine levels in human. Even though treatments of hyperhomocysteinaemic patients ongoing cardiovascular complications are commonly used, it still remains unclear above which homocysteine level a preventive therapy should be started. MATERIALS AND METHODS: In order to establish a threshold of plasma homocysteine concentration we have analyzed the hepatic cystathionine beta synthase and paraoxonase 1 activities in a moderate to intermediate murine model of hyperhomocysteinaemia. Using wild type and heterozygous cystathionine beta synthase deficient mice fed a methionine enriched diet or a control diet, we first studied the link between cystathionine beta synthase and paraoxonase 1 activities and plasma homocysteine concentration. RESULTS: Among the animals used in this study, we observed a negative correlation between plasma homocysteine level and cystathionine beta synthase activity (rho=-0.52, P=0.0008) or paraoxonase 1 activity (rho=-0.49, P=0.002). Starting from these results, a homocysteine cut-off value of 15 microm has been found for both cystathionine beta synthase (P=0.0003) and paraoxonase 1 (P=0.0007) activities. CONCLUSIONS: Our results suggest that both cystathionine beta synthase and paraoxonase 1 activities are significantly decreased in mice with a plasma homocysteine value greater than 15 microm. In an attempt to set up preventive treatment for cardiovascular disease our results indicate that treatments should be started from 15 microm of plasma homocysteine.


Subject(s)
Aryldialkylphosphatase/metabolism , Cystathionine beta-Synthase/metabolism , Homocysteine/blood , Hyperhomocysteinemia/metabolism , Animals , Disease Models, Animal , Liver/metabolism , Mice
2.
Ginekol Pol ; 70(2): 62-8, 1999 Feb.
Article in Polish | MEDLINE | ID: mdl-10349809

ABSTRACT

The aim of this study was to review 2567 deliveries in the District Hospital in Bialystok in 1997. In 2388 term labours and 179 preterm ones we noticed the congenital infections; in 90 (3.8%) and in 58 (32.4%) newborns respectively. The main etiologic factors of infections were Escherichia coli and Staphylococcus epidermidis in term newborns and Staphylococcus epidermidis and Escherichia coli in preterm babies. Clinical signs of the urinary tract infection were most frequent in mature infants, whereas the sepsis was quite common in premature newborns.


Subject(s)
Bacterial Infections/congenital , Bacterial Infections/epidemiology , Humans , Infant, Newborn , Poland/epidemiology , Risk Factors , Rural Population/statistics & numerical data , Urban Population/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL
...